Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04140175 · ClinicalTrials.gov registry record
A Study of Women Receiving Standard of Care (SOC) for the Treatment of Pelvic Pain Due to Suspected or Confirmed Endometriosis and the Impact on the Disease or Symptom Progression.
A clinical trial, sponsored by AbbVie.
- Terminated
- Registry status
- 291
- Enrollment target
NCT04140175 is a clinical trial that was terminated before completion, run by AbbVie. The registered enrollment target is 291 participants.
The verdict
NCT04140175 was terminated before completion, sponsored by AbbVie.
- TERMINATED
- Registry status
- 291 participants
- Enrollment target
Study Summary
This study will describe historic, current, and evolving treatment pathways, treatments, and interventions in women with a suspected or confirmed diagnosis of endometriosis in order to better understand the impact of early intervention on the disease or its symptoms. Length of treatment is dependent on standard of care treatment provided and all study information will be collected during routine standard of care visits.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 291 participants |
| Start Date | 2020-01-20 |
| Est. Completion | 2020-11-19 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04140175
The ClinicalTrials.gov registry entry for NCT04140175 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 291 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AbbVie, which has 526 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04140175 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04140175 about?
NCT04140175 is a clinical study titled "A Study of Women Receiving Standard of Care (SOC) for the Treatment of Pelvic Pain Due to Suspected or Confirmed Endometriosis and the Impact on the Disease or Symptom Progression.". This study will describe historic, current, and evolving treatment pathways, treatments, and interventions in women with a suspected or confirmed diagnosis of endometriosis in order to better understand the impact of early intervention on the disease or its symptoms. Length of treatment is dependent...
What is the current status of trial NCT04140175?
This trial is currently terminated. The enrollment target is 291 participants. The study started on 2020-01-20. Estimated completion is 2020-11-19.
Who is sponsoring clinical trial NCT04140175?
This trial is sponsored by AbbVie, which has 526 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.